Johnson & Johnson (JNJ) has achieved a ‘Golden Cross’, a technical indicator suggesting a shift from a bearish to a bullish trend. The stock’s 50-day moving average has crossed above the 200-day moving average, indicating strong upward momentum. This bullish signal is further supported by strong short-term strength and positive fundamental catalysts like the FDA submission for a new muscle weakness drug.
Allegion PLC (ALLE) has formed a golden cross, a technical chart pattern suggesting a potential bullish breakout. The company’s 50-day simple moving average has crossed above its 200-day simple moving average, indicating a positive trend reversal. Coupled with recent price gains and a strong Zacks Rank, ALLE appears poised for further growth. Positive earnings estimates further support this bullish outlook.
